1. Home
  2. PRT vs CTSO Comparison

PRT vs CTSO Comparison

Compare PRT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PermRock Royalty Trust Trust Units

PRT

PermRock Royalty Trust Trust Units

HOLD

Current Price

$2.10

Market Cap

27.7M

Sector

Energy

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.37

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRT
CTSO
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
29.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PRT
CTSO
Price
$2.10
$0.37
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
53.4K
247.4K
Earning Date
05-13-2026
05-01-2026
Dividend Yield
13.45%
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
$7.78
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.82
$0.35
52 Week High
$4.14
$1.22

Technical Indicators

Market Signals
Indicator
PRT
CTSO
Relative Strength Index (RSI) 42.41 45.43
Support Level $1.87 $0.36
Resistance Level $2.36 $0.72
Average True Range (ATR) 0.10 0.05
MACD -0.00 0.00
Stochastic Oscillator 32.36 29.14

Price Performance

Historical Comparison
PRT
CTSO

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: